<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">41018183</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Electro-acupuncture for irritable bowel syndrome with constipation: study protocol of a pilot, randomized, double-blinded, sham-controlled trial.</ArticleTitle><Pagination><StartPage>1632822</StartPage><MedlinePgn>1632822</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1632822</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2025.1632822</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Irritable bowel syndrome with constipation (IBS-C) is a common functional gastrointestinal disorder characterized by constipation, abdominal discomfort, and a substantial impact on patients' quality of life. While acupuncture could be effective in treating general IBS, high-quality clinical evidence specifically supporting its efficacy in IBS-C remains limited. Our study aims to address this gap by evaluating the effectiveness and safety of electro-acupuncture in managing IBS-C symptoms.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This a multicentre, randomized, double-blinded, sham-controlled trial. A total of 60 IBS-C patients are randomized to receive either electro-acupuncture (n&#x202f;=&#x202f;30) or sham acupuncture (n&#x202f;=&#x202f;30). Patients undergo a 2-week screening period, followed by 6&#x202f;weeks of treatment (12 sessions) and 6&#x202f;weeks of follow-up. From the beginning of the screening period to the end of the trial, patients are instructed to complete daily diaries recording bowel movement timing, stool consistency, straining severity, sensation of complete or incomplete evacuation, and the name and dosage of any medications taken. The primary outcome measure follows the FDA-recommended endpoint for IBS-C trials. Additionally, biological samples are collected to explore the potential mechanisms underlying the effects of acupuncture on IBS-C pathology.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION" NlmCategory="UNASSIGNED">The protocol (version 1.4.4) has received approval from the Institutional Review Board of Nanyang Technological University (IRB-2023-451).</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER" NlmCategory="UNASSIGNED">NCT06219707.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Lam, Chen, Siah, Thakur and Zhong.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>Wai Ching</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Biomedical Sciences and Chinese Medicine, School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Huangyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Biomedical Sciences and Chinese Medicine, School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siah</LastName><ForeName>Kewin Tien Ho</ForeName><Initials>KTH</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, University Medicine Cluster, National University Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thakur</LastName><ForeName>Elyse R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Atrium Health, Charlotte, NS, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Gastroenterology, Wake Forest University School of Medicine, Winston-Salem, NS, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Linda L D</ForeName><Initials>LLD</Initials><AffiliationInfo><Affiliation>Biomedical Sciences and Chinese Medicine, School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT06219707</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acupuncture</Keyword><Keyword MajorTopicYN="N">constipation</Keyword><Keyword MajorTopicYN="N">food and drug administration</Keyword><Keyword MajorTopicYN="N">irritable bowel syndrome</Keyword><Keyword MajorTopicYN="N">randomized controlled trial</Keyword></KeywordList><CoiStatement>Elyse R. Thakur has grant funding from the American Neurogastroenterology and Motility Society (ANMS-Ironwood Diversity Development Award). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>29</Day><Hour>13</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>29</Day><Hour>13</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41018183</ArticleId><ArticleId IdType="pmc">PMC12463899</ArticleId><ArticleId IdType="doi">10.3389/fneur.2025.1632822</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. Lancet. (2020) 396:1675&#x2013;88. doi: 10.1016/S0140-6736(20)31548-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31548-8</ArticleId><ArticleId IdType="pubmed">33049223</ArticleId></ArticleIdList></Reference><Reference><Citation>Almario CV, Sharabi E, Chey WD, Lauzon M, Higgins CS, Spiegel BMR. Prevalence and burden of illness of Rome IV irritable bowel syndrome in the United States: results from a Nationwide cross-sectional study. Gastroenterology. (2023) 165:1475&#x2013;87. doi: 10.1053/j.gastro.2023.08.010, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2023.08.010</ArticleId><ArticleId IdType="pubmed">37595647</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study. Gastroenterology. (2021) 160:99&#x2013;114.e3. doi: 10.1053/j.gastro.2020.04.014, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.04.014</ArticleId><ArticleId IdType="pubmed">32294476</ArticleId></ArticleIdList></Reference><Reference><Citation>Fond G, Loundou A, Hamdani N, Boukouaci W, Dargel A, Oliveira J, et al. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci. (2014) 264:651&#x2013;60. doi: 10.1007/s00406-014-0502-z, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-014-0502-z</ArticleId><ArticleId IdType="pubmed">24705634</ArticleId></ArticleIdList></Reference><Reference><Citation>Sendzischew Shane MA, Ruddy J, Cline M, Rosenbaum DP, Edelstein S, Moshiree B. Review of the patient burden and therapeutic landscape of irritable bowel syndrome with constipation in the United States. Clin Exp Gastroenterol. (2024) 17:227&#x2013;53. doi: 10.2147/CEG.S464375, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CEG.S464375</ArticleId><ArticleId IdType="pmc">PMC11303673</ArticleId><ArticleId IdType="pubmed">39114809</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangan V, Ballou S, Shin A, Camilleri M, Beth Israel Deaconess Medical Center GI Motility Working Group. Lembo A. Use of treatments for irritable bowel syndrome and patient satisfaction based on the IBS in America survey. Gastroenterology. (2020) 158:786&#x2013;788.e1. doi: 10.1053/j.gastro.2019.10.036, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2019.10.036</ArticleId><ArticleId IdType="pmc">PMC7212496</ArticleId><ArticleId IdType="pubmed">31711922</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbara G, Barbaro MR, Fuschi D, Palombo M, Falangone F, Cremon C, et al. Inflammatory and microbiota-related regulation of the intestinal epithelial barrier. Front Nutr. (2021) 8:718356. doi: 10.3389/fnut.2021.718356, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.718356</ArticleId><ArticleId IdType="pmc">PMC8475765</ArticleId><ArticleId IdType="pubmed">34589512</ArticleId></ArticleIdList></Reference><Reference><Citation>Camilleri M, Lasch K, Zhou W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. (2012) 303:G775&#x2013;85. doi: 10.1152/ajpgi.00155.2012, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00155.2012</ArticleId><ArticleId IdType="pubmed">22837345</ArticleId></ArticleIdList></Reference><Reference><Citation>Simr&#xe9;n M, Barbara G, Flint HJ, Spiegel BMR, Spiller RC, Vanner S, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. (2013) 62:159&#x2013;76. doi: 10.1136/gutjnl-2012-302167, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2012-302167</ArticleId><ArticleId IdType="pmc">PMC3551212</ArticleId><ArticleId IdType="pubmed">22730468</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna-Jairala I, Drossman DA. Central neuromodulators in irritable bowel syndrome: why, how, and when. Am J Gastroenterol. (2024) 119:1272&#x2013;84. doi: 10.14309/ajg.0000000000002800, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000002800</ArticleId><ArticleId IdType="pmc">PMC11208063</ArticleId><ArticleId IdType="pubmed">38595149</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz MNM, Kumar J, Muhammad Nawawi KN, Raja Ali RA, Mokhtar NM. Irritable bowel syndrome, depression, and neurodegeneration: a bidirectional communication from gut to brain. Nutrients. (2021) 13:3061. doi: 10.3390/nu13093061, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13093061</ArticleId><ArticleId IdType="pmc">PMC8468817</ArticleId><ArticleId IdType="pubmed">34578939</ArticleId></ArticleIdList></Reference><Reference><Citation>Mudyanadzo TA, Hauzaree C, Yerokhina O, Architha NN, Ashqar HM. Irritable bowel syndrome and depression: a shared pathogenesis. Cureus. (2018) 10:e3178. doi: 10.7759/cureus.3178, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.3178</ArticleId><ArticleId IdType="pmc">PMC6197537</ArticleId><ArticleId IdType="pubmed">30357038</ArticleId></ArticleIdList></Reference><Reference><Citation>Drossman DA, Tack J, Ford AC, Szigethy E, T&#xf6;rnblom H, Van Oudenhove L. Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction): a Rome foundation working team report. Gastroenterology. (2018) 154:1140&#x2013;1171.e1. doi: 10.1053/j.gastro.2017.11.279, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2017.11.279</ArticleId><ArticleId IdType="pubmed">29274869</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaklai K, Pattanakuhar S, Chattipakorn N, Chattipakorn SC. The role of acupuncture on the gut-brain-microbiota axis in irritable bowel syndrome. Am J Chin Med. (2021) 49:285&#x2013;314. doi: 10.1142/S0192415X21500154, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S0192415X21500154</ArticleId><ArticleId IdType="pubmed">33622207</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu MM, Guo Y, Chen Y, Zhang W, Wang L, Li Y. Electro-acupuncture promotes gut motility and alleviates functional constipation by regulating gut microbiota and increasing butyric acid generation in mice. J Integr Med. (2023) 21:397&#x2013;406. doi: 10.1016/j.joim.2023.05.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joim.2023.05.003</ArticleId><ArticleId IdType="pubmed">37331860</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Wang J, Zhang C, Guo Y, Zhao M, Zhang M, et al. The efficacy and neural mechanism of acupuncture therapy in the treatment of visceral hypersensitivity in irritable bowel syndrome. Front Neurosci. (2023) 17:1251470. doi: 10.3389/fnins.2023.1251470, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2023.1251470</ArticleId><ArticleId IdType="pmc">PMC10507180</ArticleId><ArticleId IdType="pubmed">37732301</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei L, Geng H, Guo J, Yang G, Wang L, Shen R, et al. Effect of acupuncture in patients with irritable bowel syndrome: a randomized controlled trial. Mayo Clin Proc. (2020) 95:1671&#x2013;83. doi: 10.1016/j.mayocp.2020.01.042, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.01.042</ArticleId><ArticleId IdType="pubmed">32499125</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider A, Enck P, Streitberger K, Weiland C, Bagheri S, Witte S, et al. Acupuncture treatment in irritable bowel syndrome. Gut. (2006) 55:649&#x2013;54. doi: 10.1136/gut.2005.074518, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2005.074518</ArticleId><ArticleId IdType="pmc">PMC1856122</ArticleId><ArticleId IdType="pubmed">16150852</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao JM, Lu JH, Yin XJ, Wu LY, Bao CH, Chen XK, et al. Comparison of electroacupuncture and mild-warm moxibustion on brain-gut function in patients with constipation-predominant irritable bowel syndrome: a randomized controlled trial. Chin J Integr Med. (2018) 24:328&#x2013;35. doi: 10.1007/s11655-018-2838-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11655-018-2838-0</ArticleId><ArticleId IdType="pubmed">29752611</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J, Sun JH, Chen L, Geng H, Yang GH, Shen RR, et al. Bidirectional regulation of acupuncture: a subgroup analysis of multicenter randomized controlled trial of acupuncture with Tiaoshen Jianpi for irritable bowel syndrome. Zhongguo Zhen Jiu. (2021) 41:845&#x2013;50. doi: 10.13703/j.0255-2930.20201111-k0001, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.13703/j.0255-2930.20201111-k0001</ArticleId><ArticleId IdType="pubmed">34369692</ArticleId></ArticleIdList></Reference><Reference><Citation>MacPherson H, Jobst KA. Improving the reporting of interventions in clinical trials of acupuncture: the updated and revised STRICTA. J Altern Complement Med. (2010) 16:929&#x2013;30. doi: 10.1089/acm.2010.0558, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/acm.2010.0558</ArticleId><ArticleId IdType="pubmed">20839969</ArticleId></ArticleIdList></Reference><Reference><Citation>Butcher NJ, Monsour A, Mew EJ, Chan AW, Moher D, Mayo-Wilson E, et al. Guidelines for reporting outcomes in trial reports: the CONSORT-outcomes 2022 extension. JAMA. (2022) 328:2252&#x2013;64. doi: 10.1001/jama.2022.21022, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.21022</ArticleId><ArticleId IdType="pubmed">36511921</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmulson MJ, Drossman DA. What is new in Rome IV. J Neurogastroenterol Motil. (2017) 23:151&#x2013;63. doi: 10.5056/jnm16214, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.5056/jnm16214</ArticleId><ArticleId IdType="pmc">PMC5383110</ArticleId><ArticleId IdType="pubmed">28274109</ArticleId></ArticleIdList></Reference><Reference><Citation>Irritable Bowel Syndrome  (2012). Clinical evaluation of products for treatment [internet]. Food and Drug Administration. Available online at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/irritable-bowel-syndrome-clinical-evaluation-products-treatment (Accessed May 1, 2025).</Citation></Reference><Reference><Citation>Song J, Yang L, Su S, Piao MY, Li BL, Liang LX, et al. The diagnosis performance of the TCM syndromes of irritable bowel syndrome by gastroenterologists based on modified simple criteria compared to TCM practitioners: a prospective, multicenter preliminary study. Evid Based Complement Alternat Med. (2020) 2020:9507674. doi: 10.1155/2020/9507674, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/9507674</ArticleId><ArticleId IdType="pmc">PMC7368204</ArticleId><ArticleId IdType="pubmed">32695213</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JS. Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies. Trends Neurosci. (2003) 26:17&#x2013;22. doi: 10.1016/S0166-2236(02)00006-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-2236(02)00006-1</ArticleId><ArticleId IdType="pubmed">12495858</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Yan S, Wu J, He L, Li N, Dong G, et al. Acupuncture for chronic severe functional constipation: a randomized trial. Ann Intern Med. (2016) 165:761&#x2013;9. doi: 10.7326/M15-3118, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M15-3118</ArticleId><ArticleId IdType="pubmed">27618593</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei L, Zhu L, Sun J, Wu X, Chen L. Constipation predominant irritable bowel syndrome treated with acupuncture for regulating the mind and strengthening the spleen: a randomized controlled trial. Zhongguo Zhen Jiu. (2015) 35:1095&#x2013;8. PMID:</Citation><ArticleIdList><ArticleId IdType="pubmed">26939315</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim TH, Lee MS, Birch S, Alraek T. Plausible mechanism of sham acupuncture based on biomarkers: a systematic review of randomized controlled trials. Front Neurosci. (2022) 16:834112. doi: 10.3389/fnins.2022.834112, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.834112</ArticleId><ArticleId IdType="pmc">PMC8850388</ArticleId><ArticleId IdType="pubmed">35185461</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundeberg T, Lund I, Sing A, N&#xe4;slund J. Is placebo acupuncture what it is intended to be? Evid Based Complement Alternat Med. (2011) 2011:932407. doi: 10.1093/ecam/nep049, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecam/nep049</ArticleId><ArticleId IdType="pmc">PMC3139519</ArticleId><ArticleId IdType="pubmed">19525330</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>